 |
3
Enhancing Provider Dynamics
|
Enhancing Provider Dynamics: Pharmacy
Blockbuster Drugs Potentially Going Off-Patent
With five blockbuster drugs likely facing patent expiration in 2006, over $10 billion is potentially vulnerable to generic substitution.
| Possible Patent Expiration |
Drug Brand Name |
Use |
2004 U.S. Sales* (Billions) |
| 2006 |
Zocor (Merck) |
Hyperlipidemian |
$5.5 |
| Zoloft (Pfizer) |
Depression |
$3.0 |
| Pravachol (Bristol-Myers Squibb) |
Hyperlipidemian |
$1.9 |
| Ambien (Sanofi) |
Insomnia |
$1.8 |
| Allegra (Aventis) |
Allergies |
$1.5 |
